The "somnolence syndrome" consists of drowsiness, lethargy, anorexia, and irritability occuring in about 600% of children six weeks after prophylactic irradiation of the central nervous system in acute leukaemia or non-Hodgkin's lymphoma.1 It is associated with electroencephalographic (EEG) abnormalities.1 We have studied 27 children prospectively to evaluate EEG changes occurring in children after irradiation of the central nervous system. We have also attempted to correlate the occurrence of the syndrome with the fractionation of radiotherapy and with the subsequent survival and well-being of the children.
Patients, methods, and results
The study group consisted of 17 children with acute lymphoblastic leukaemia and 10 children with non-Hodgkin's lymphoma; there were 18 boys and nine girls and their median age was 5-2 years. Twenty-four children received 2400 rads of cranial irradiation with five doses of 10 mg/M2 (maximum 12 mg) methotrexate intrathecally. Three children also received spinal irradiation with 1000 rads and no intrathecal methotrexate.
Seventeen of the 27 children (63°' ) had clinically significant somnolence after cranial irradiation. The syndrome occurred irrespective of type of disease, sex, or age of the patient. EEG abnormalities occurred in nine out of ten children who had EEG examination during somnolence (see figure) and No. subsequently returned to normal in eight of these children. The abnormalities consisted of pathological symmetrical slowing of the dominant rhythm or increase to excess of the diffuse theta and slow components, given the levels of awareness of the children. The one child whose EEG failed to return to normal died with systemic relapse of lymphoma 11 months after diagnosis. Children receiving their radiotherapy in fewer than 16 fractions and less than 22 days had a higher incidence of somnolence (12 out of 16 children) than those receiving more than 19 fractions in more than 24 days (four out of 10 children somnolent). Although this disparity could be due to chance variation, the difference may be due to the greater biological effect of radiation when given in fewer fractions.
There was no significant difference between the survival of children who developed somnolence (median survival 36 months) and that of nonsomnolent children (median survival 27 months), nor was there an increase in central nervous system relapse in somnolent children. Somnolence was unrelated to taking adriamycin or colaspase as part of the systemic chemotherapy.
Comment
The benign nature of the somnolence syndrome is confirmed in this study. Knowledge of its existence is important for reassuring children and their parents and for preventing unnecessary investigation.
We are very grateful to Mrs Sharon Willmott for co-ordinating this study and to Mrs Jane Thomas and Mrs Jill Nichol for carrying out the electroencephalography. We are indebted to our colleagues who kindly referred these children to us. The use of kilopascals for measuring blood pressure was recommended in 1960 by the General Conference on Weights and Measures in its authorisation of the SI system,1 but it has not so far been accepted by the medical profession. I have been using kilopascals since 1976 and have found the changeover quite simple.
Conversion from mm Hg to kPa I recalibrated the near side of the 2 mm scale on my wall mercury sphygmomanometer in kilopascals (integers only) and started to use this exclusively. For the first three months the opposite 2 mm scale was left to make conversion easier. Then I recalibrated this as well and converted to mm Hg only when essential; all blood pressure readings for FP7 and 8 forms, insurance reports, maternity co-operation cards, and hospital correspondence are now given in kilopascals, the mm Hg equivalents being added in parentheses where necessary.
A pressure of 1 kilopascal (kPa)-the force exerted by 1 newton on an area of 1 m2-is equal to 7 5 mm Hg (see 
